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Abstract Searching for effective biomarkers is one of the
most challenging tasks in the research field of Autism
Spectrum Disorder (ASD). Magnetic resonance imaging
(MRI) provides a non-invasive and powerful tool for
investigating changes in the structure, function, maturation,
connectivity, and metabolism of the brain of children with
ASD. Here, we review the more recent MRI studies in
young children with ASD, aiming to provide candidate
biomarkers for the diagnosis of childhood ASD. The
review covers structural imaging methods, diffusion tensor
imaging, resting-state functional MRI, and magnetic reso-
nance spectroscopy. Future advances in neuroimaging
techniques, as well as cross-disciplinary studies and large-
scale collaborations will be needed for an integrated
approach linking neuroimaging, genetics, and phenotypic
data to allow the discovery of new, effective biomarkers.
Keywords Autism spectrum disorder  Biomarker 
Neuroimaging  Structural MRI  Diffusion tensor
imaging  Resting-state functional MRI  Magnetic
resonance spectroscopy  Children  Human
Introduction
Autism spectrum disorder (ASD) is a neurodevelopmental
disorder that has a strong genetic basis, a heterogeneous
etiology, and various clinical presentations. The core
symptoms of ASD include: (1) deficits in social commu-
nication and social interaction, and (2) restricted, repetitive
patterns of behavior, interests, or activities [1]. The
prevalence of ASD has dramatically increased recently
from 4 in 10000 to 1 in 68 children [2, 3]. Along with the
soaring incidence of ASD, significant financial and emo-
tional costs to the individuals and their families, as well as
the numerous pressures on our medical, social, and politi-
cal lives have been engendered [4]. Hence, determining the
causes and making an accurate diagnosis as well as early
and effective intervention seem crucial for society [5].
So far, the diagnosis of ASD and the selection criteria
for clinical trials have been guided by the Diagnostic and
Statistical Manual of Mental Disorders or behavioral
diagnostic scales. The apparent disadvantage of symptom-
based criteria is that a similar symptom or phenotype may
arise from diverse sets of biochemical processes, especially
for disorders with numerous genetic or environmental
factors like ASD [6]. In the past decade, searching for
genetic biomarkers has been one of the hottest spots in
ASD research. Numerous related genes have been reported
including NRXN1, SHANK3, SHANK2, MECP2, SNC2A,
CHD8, DYRKIA, POG2, GRIN2B, KATNAL2, NLGN3,
NLGN4, CNTN4, CDH10, CDH9, and SEMA5A [7–17].
Unfortunately, the genetic underpinnings of ASD are nei-
ther simple nor consistent, considering that only 10%–38%
of ASD cases have been reported with known genetic
deficits [18–20]. Because of this heterogeneity and com-
plexity, interest and efforts into searching for more
biomarkers and quantifiable parameters are increasing in
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order to facilitate early and reliable diagnosis, as well as to
subgroup patients sharing common pathophysiological
underpinnings.
Magnetic resonance imaging (MRI), a non-invasive
examination tool, has been widely applied to ASD popu-
lations to delineate the developmental trajectory of the
brain. Major advances in structural and functional MRI
techniques in the past decades have greatly enriched our
understanding of neuropathological differences in ASD
[19, 21, 22]. Generally, structural MRI has revealed ASD
to be a disorder with general and regional brain enlarge-
ment, especially in the frontotemporal cortices, while
functional MRI studies have highlighted diminished con-
nectivity, especially between frontal-posterior regions
[19, 21–25].
Here, we review recent MRI studies (since 2000) in
young children with ASD, aiming to provide effective
biomarkers for the diagnosis of childhood ASD. We focus
on studies using structural imaging methods, structural
connectivity analyses, diffusion tensor imaging (DTI),
neurochemical or metabolic quantification methods, and
magnetic resonance spectroscopy (MRS), as well as func-
tional connectivity analyses with resting-state functional
MRI (rs-fMRI). We do not consider task-based functional
methods, since it is almost impossible to keep a young
child awake and still during a functional scan. We place the
emphasis on young ASD children because in adolescents
and adults the altered brain structures and activities may
merely reflect the social deprivation experience elicited by
reduced social attention during childhood. Therefore, it is
impossible to tell whether observed functional or structural
differences are the cause or the result of ASD neu-
ropathology. Another reason is based on brain plasticity.
There is growing evidence that the first 3 years of life is a
particularly critical developmental period for children with
ASD [26, 27]. Thus, the earlier the abnormal neurodevel-
opmental trajectory (even in infants and toddlers) is iden-
tified, the better guided intervention strategies for ASD
children can be achieved.
Structural MRI
Structural MRI analysis for neurodevelopmental disorders
began to emerge in the 1990s when it focused on the
neuroanatomical aspects of brain development. It has been
used to measure the total brain volume and volumes of
specific structures. Earlier studies used manual delineation
for the gray (GM) and white matter (WM) to calculate the
volumes of specific regions of interest (ROIs). With tech-
nical developments, it is now possible to use program
codes to measure the volumes automatically, allowing
large data sets to be processed more efficiently [28]. Based
on the different analytic methods for structural data,
structural MRI studies can be classified into voxel-based
morphometry (VBM) and surface-based morphometry
(SBM) [29]. VBM targets tissue density and usually
focuses on relative GM concentration or volume, or
regional volume differences of a certain tissue. SBM
addresses topological features, like surface curvature and
degree of folding [29, 30]. Notably, brain volume and
surface curvature have been hypothesized to have disso-
ciable developmental trajectories with, putatively, different
genetic and neurodevelopmental bases [22, 31, 32].
Table 1 summarizes the findings of structural MRI studies
in children.
Cortex
The most consistent observation regarding structural cor-
tical changes in young ASD children versus controls is the
increased total volume both in the cortical GM and WM
[22, 30, 33, 34]. Increased GM volume (GMV) and WM
volume (WMV) have been found in the frontal and tem-
poral lobes and are less pronounced in the parietal and
occipital lobes. For example, Carper et al. (2002) revealed
increased frontal and temporal GMV and frontal and
parietal WMV at young ages (2–4 years old) [35]. Sparks
et al. (2002) likewise observed increased cerebral volumes
in autistic children aged 4–6 years [36]. Akshoomoff et al.
(2004) reported increased total brain volume (TBV), as
well as significantly increased WMV and GMV in children
of 4–6 years with low-functioning autism compared with
high-functioning autism (HFA) [37]. Hazlett et al. (2006)
investigated 51 younger autistic children and 25 typically-
developing controls (aged 18–35 months). They reported
increased cerebral GMV and WMV in the brains of the
autistic group [38]. In a group of 1.5–5 year-old autistic
children, Schumann et al. (2010) found no changes in the
occipital lobe but enlarged cerebral GMV in the frontal,
temporal, and parietal lobes, as well as in the cingulate
gyrus (located in the limbic lobe) [39]. Hazlett et al. (2011)
compared the TBV of 6-month-old high-risk infants with
autistic siblings with low-risk infants without autistic
family members. They found no significant difference in
the cerebrum or lateral ventricle volumes, consistent with
the hypothesis that the brain enlargement might be a
postnatal event, occurring at *12 months of age [34].
However, Shen et al. (2013) identified excessive cere-
brospinal fluid (CSF) over the frontal lobes at 6–9 months
of age but no such difference at 12–15 and 18–24 months
[40]. Recently, Gori et al. (2015) extracted features from
GM, WM, and CSF measurements to classify autistic and
control brains in 4-year-old males. They found that only
GM features in different sub-regions showed up to 80%
classification performance [41].
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SBM studies have only been performed with older
autistic children. For instance, Hardan et al. (2006) applied
atlas-based SBM to children aged 10 years. They found no
changes in the frontal or occipital lobes but increased total
cerebral sulcal and gyral thicknesses in the temporal and
parietal lobes [42]. Two years later, Hardan et al. (2009)
performed follow-up scans on the same group of autistic
children, and revealed decreased cortical thickness in the
frontal, temporal, and occipital lobes compared to controls
[43]. Moreover, another SBM study by Jiao et al. (2010) on
9-year-old autistic children showed decreased thickness in
the right entorhinal, right lateral orbitofrontal, left lateral
orbitofrontal, right medial orbitofrontal, left medial orbi-
tofrontal cortex, and right pars triangularis, as well as
increased thickness in the left caudal anterior cingulate
cortex and left frontal pole [44]. More recently, Dierker
et al. (2015) found bilateral differences in sulcal depth in
the anterior-insula, frontal-operculum, and temporal-pari-
etal junctions [45].
According to the above studies, the main differences in
the cerebrum of young autistic children are the enlarged
total volume of both GM and WM. The most prominent
differences were found in the frontal and temporal lobes as
well as precentral regions. The growing cerebral volume in
early childhood indicates simultaneously decreasing GM
and WM density [40]. Interestingly, the changes seem to
begin in the autistic cerebrum at the age of *12 months,
i.e., the cerebral enlargement does not occur earlier than 12
months of age [34, 46].
Cerebellum and Subcortical Areas
Cerebellum and Vermis
Cerebellar dysfunction may play a crucial role in the eti-
ology of ASD [47, 48]. The cerebellum is considered to be
one of the most consistent sites of abnormality in autism
[49, 50]. Most morphometric studies of ASD children have
reported increased total cerebellar volume [36, 51, 52] and
decreased GMV in some subregions, e.g., crus I and lob-
ules VIII and IX [53–55]. However, the results on WMV
have been inconsistent. For instance, Courchesne et al.
(2001) found a larger cerebellar WMV in 2–3 year-old
autistic children [33], while McAlonan et al. (2005)
reported decreased WM density in the cerebellum [56].
Regarding the vermis, the results are also contradictory. In
older children, Elia et al. (2000) measured the sizes of the
cerebellar areas in 22 autistic children and reported no
abnormalities in the total vermis, vermis lobules VI–VII,
pons, and midbrain [57]. In contrast, Akshoomoff et al.
(2004) revealed larger cerebellar WMV and GMV and
increased areas of the anterior and posterior cerebellar
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Amygdala
The amygdala has been the focus of several studies in
children with ASD, given its important role in socio-
emotional processing [58–61]. Sparks et al. (2002) inves-
tigated 29 autistic children and typically-developing con-
trols with an average age of 3.9 years and showed bilateral
enlargement of the amygdala that was proportional to the
overall increase in total cerebral volume [36]. Munson
et al. (2006) argued that the enlargement was only found in
the right amygdala at the age of 3–4 years [62]. Nordahl
et al. (2012) scanned 85 autistic children aged 37 months
on average, and re-scanned 45 members of the same group
one year later. They found an increased amygdala volume
in both cases, confirming that the enlargement starts at*3
years [63].
Corpus Callosum
A decreased corpus callosum (CC) size in the autistic pop-
ulation has been consistently reported, including reductions
localized in the mid-sagittal area, anterior CC, body, and
posterior splenium [2, 22, 43, 64–69]. A reduced CC has
been associated with reduced integration of information and
slower processing [2, 68, 69]. However, to our knowledge,
CC changes in the early childhood period have not yet been
studied. A report by Frazier et al. (2012) investigated 19
autistic children with a mean age of 10.6 years and found
consistent reductions in the total CC volume [65].
Basal Ganglia
The basal ganglia play an important role in cognition and
motor control via participation in frontostriatal, thalamo-
cortical, and limbic circuits [70–73]. In neuroimaging
studies of ASD, the basal ganglia have been studied
regarding their association with repetitive behaviors
[74, 75]. The most consistent finding is an increased cau-
date volume [76, 77]. Unfortunately, most of the studies
were conducted in adults or late adolescence but not in
childhood.
Hippocampus
Sparks et al. (2002) found enlarged hippocampi in autistic
children at the ages of 3–4 years [36]. Similarly, in
7.5–12.5 year-olds, Schumann et al. (2004) also revealed
enlarged hippocampi, especially in an HFA group [78],
while in a 10 year-old group, Barnea-Goraly et al. (2014)
observed an enlargement only in the right hippocampus
[79]. Interestingly, in an older group, Barnea-Goraly et al.
(2014) reported no difference in the hippocampus of both
hemispheres. These findings indicate that the hippocampus
in ASD has an unbalanced growth pattern during early
brain development [79].
Conclusions
The most consistent structural MRI finding is the increased
growth of total cortical volume in early ASD children. A
similar trend has also been demonstrated in some subcor-
tical brain regions (e.g., amygdala and hippocampus) and
the cerebellum. Interestingly, studies comparing ASD
adolescents or adults with controls did not find such dif-
ferences and have even reported decreased TBV in ASD
patients [35, 80]. Thus, it seems as if brain development
during early childhood in ASD is more voluminous than in
a typically-developing brain, especially in the frontal and
temporal lobes, followed by a possibly reduced volumetric
capacity of the brain after adolescence [81, 82].
Diffusion Tensor Imaging (DTI)
Molecular studies have demonstrated dysmaturation of the
WM characterized by microstructural changes or disorga-
nization in the brains of autistic populations [83, 84]. It has
been reported that synaptogenesis is altered in children
with ASD, affecting myelination, and thus compromising
WM integrity [85]. DTI, as a non-invasive tool, has been
applied in the last decade to developing brains to study
both the local connectivity and WM tracts as well as fas-
ciculi that connect regions and lobes [2, 86–90]. Metrics
such as fractional anisotropy (FA), and mean diffusivity
(MD) have been used to measure the directionality and the
amount of diffusion, respectively, in a particular ROI or at
the level of individual voxels. The most commonly-used
DTI methods are tractography, voxel-wise analysis, and
tract-based spatial statistics (TBSS). Table 2 summarizes
the findings of DTI studies in children.
Tractography
The majority of tractography studies have found reduced
FA and increased MD, indicating more WM microstruc-
tural disorganization in the frontal and temporal lobes or
dominant tracts. For example, Sundaram et al. (2008)
applied deterministic tractography to analyze WM abnor-
malities in the frontal lobe and checked for short-range
connectivity changes in ASD children. They reported
higher MD in the whole frontal lobe as well as reduced FA
for short-range fibers in ASD children [91]. Hong et al.
(2011) also used deterministic tractography to examine
connectivity in the CC in HFA children. They revealed
decreased WM density in the anterior third of the CC, as
well as higher MD and a lower fiber number in the anterior
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third of the transcallosal fiber tracts [92]. Using deter-
ministic tractography, Nagae et al. (2012) revealed higher
MD in the temporal portion of the left superior longitudinal
fasciculus in ASD children with language impairment, as
well as a significant negative correlation between MD and
language score [93]. Wolff et al. (2012) investigated WM
fiber tracts in a group of high-risk infants from 6 to 24
months old. Higher FA values were found in the fornix,
uncinate fasciculus, and inferior longitudinal fasciculus at 6
months, whereas no such differences were observed at 12
months [94]. Nair et al. (2013) used both fMRI and prob-
abilistic DTI tractography to assess the integrity of thala-
mo-cortical connectivity in children and adolescents with
ASD. They reported increased MD in the thalamo-cortical
connections, and decreased functional connectivity in the
thalamo-cortical circuitry, as well as a negative correlation
between the fronto-thalamic FA and the social and total
Autism Diagnostic Observation Schedule score [95]. More
recently, Joseph et al. (2014) applied both structural MRI
and probabilistic DTI tractography to investigate the ana-
tomo-behavioral relationship addressing language ability in
young ASD children. In the ASD children, they found no
difference in GM asymmetries but decreased leftward
volume and radial diffusivity of the arcuate fasciculus [96].
Voxel-Wise Analysis
Voxel-wise analysis is used to find areas of significant
difference and to overcome possible user bias. Cheung
et al. (2009) reported reduced FA in bilateral prefrontal and
temporal regions as well as the frontal striato-temporal and
posterior brain pathways that are associated with commu-
nication and social reciprocity impairment and repetitive
behavior [97]. Ke et al. (2009) investigated the WM
abnormalities in a group of Chinese HFA children. The
voxel-wise whole-brain analysis of FA showed decreased
WM density in the right frontal lobe, left parietal lobe, and
right anterior cingulate [98]. Barnea-Goraly et al. (2010)
found reduced FA in age-matched unaffected siblings as
compared to children with ASD, suggesting that this may
be a potential marker of genetic risk [99]. Poustka et al.
(2012) revealed decreased FA values in the uncinate fas-
ciculus and right superior longitudinal fasciculus as well as
a negative correlation between the FA values of the
affected fiber tracts and the severity of ASD symptoms
[100]. A more recent study by Peterson et al. (2015) found
widespread increases in MD in many regions of the left
hemisphere in children with ASD as compared to typically-
developing children [101], supporting the left hemispheric
abnormality or atypical hemispheric dominance that has
been hypothesized in ASD for the past three decades
[102–104]. Peterson et al. (2015) used an atlas-based ROI
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MD of the outer-zone cortical WM, suggesting
hypomyelination and increased short-range cortico-cortical
connections which might be due to the early WM over-
growth [101].
Tract-Based Spatial Statistics (TBSS)
A further innovative method of DTI analysis is TBSS
[105]. This method provides advantages over traditional
voxel-wise analysis, since it does not require smoothing
and allows for a higher spatial comparability. A mean FA
skeleton is built and thresholded to exclude areas of high
inter-individual variability. Each individual’s FA map is
then projected onto the skeleton to collect standard voxel-
wise FA statistics across all the individuals. Kumar et al.
(2010) combined deterministic tractography and TBSS to
investigate the CC region in 5-year-old ASD children.
They found lower FA, higher MD, larger numbers of
streamlines and voxels, and longer streamlines as well as
correlation between macrostructural changes in the unci-
nate fasciculus and the score on the Gilliam Autism Rating
Scale [106]. Weinstein et al. (2011) reported increased FA
within the genu and body of the CC, left superior longi-
tudinal fasciculus, and right and left cingulum in a group of
very young ASD children using TBSS. The tractography
revealed that the increased FA was concentrated in the
mid-body of the CC and in the left cingulum [107]. Jou
et al. (2011) found reduced FA in the forceps minor,
inferior fronto-occipital fasciculus, and superior longitu-
dinal fasciculus [88]. Shukla et al. (2011) demonstrated
reduced FA and higher MD in the CC, anterior and pos-
terior limbs of the internal capsule, inferior longitudinal
fasciculus, inferior fronto-occipital fasciculus, superior
longitudinal fasciculus, cingulum, anterior thalamic radia-
tion, and corticospinal tract [85]. Similarly, Walker et al.
(2012) revealed decreased FA values in various brain
regions and increased MD in some tracts [108].
Conclusions
Studies using voxel-wise analysis have revealed decreased
FA and increased MD in the major WM tracts of ASD
children. However, the voxel-wise analysis of DTI has
methodological disadvantages such as the dependency on
the size of the smoothing kernel and the hindrance of
confident conclusions [30]. TBSS overcomes these flaws
and has been used in the majority of more recent and on-
going tractography studies. Predominantly the latter have
revealed reduced FA and higher diffusivity in the main
tracts in ASD children, including the uncinate fasciculus,
arcuate fasciculus, cingulum bundle, inferior longitudinal
fasciculus, and inferior fronto-occipital fasciculus.
Resting-State Functional Magnetic Resonance
Imaging
Brain connectomics is a relatively new field of research
that maps the brain’s large-scale functional networks ‘‘at
rest’’. Correlated and anti-correlated fMRI signals are
measured without performing specific tasks. These signals
imply a functional connectivity that reflects structural
connectivity [109, 110]. They can be used to explore both
the spatial and temporal deviations of the topology of
atypical neurodevelopmental processes [111]. Table 3
summarizes the findings of rs-fMRI studies in children.
In an attempt to elucidate putative neurobiological
underpinning mechanisms, Just et al. (2004) proposed the
‘‘hypoconnectivity theory of ASD’’, claiming that the deficit
of integration of neuronal information in ASD might be
associated with an overall under-functioning of the brain’s
integrative circuitry [112]. However, Courchesne and Pierce
(2005) suggested that the developmental trajectory for
functional brain connectivity in ASD individuals is charac-
terized by both an early local hyperconnectivity and a long-
distance hypoconnectivity of the prefrontal cortex based on
the findings of an increased short-range (local) connectivity
within the frontal lobe but a decreased degree of functional
long-range (global) connectivity with the rest of the brain
[113]. DiMartino et al. (2011) found only hyperconnectivity
in the superior temporal gyrus, insula, and brainstem areas
[114]. Moreover, Lynch et al. (2013) and Uddin et al. (2013)
both demonstrated increased connectivity in the cingulate
cortex and inferior and superior frontal gyri, as well as other
specific areas [115, 116]. However, other childhood ASD
studies mostly revealed reduced long-range connectivities
across different brain regions [95, 117–119]. Thus, it has
been suggested that the increased local connectivity in ASD
children results from overcompensation for the reduced
long-range connectivity [95].
1H-MRS Metabolite Spectrum
Neurochemicals are involved in cortical activity as well
as in the metabolic processes in the brain. Each
metabolite has a unique chemical shift which acts as a
signature that is used for the quantification of that specific
metabolite. The most common method of metabolite
quantification in vivo is through the proton resonance of
hydrogen (1H) atoms [120]. 1H-magnetic resonance
spectroscopy (1H-MRS) is a non-invasive imaging tech-
nique that estimates specific chemical metabolites [121].
Previous studies mainly used 1H-MRS to quantify creatine
and phosphocreatine (Cr?PCr), a measure of cellular
energy metabolism [122]; N-acetylaspartate (NAA), a
marker of neuronal density and activity [123]; choline-
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containing compounds, a measure primarily reflecting the
constituents of cell membranes [122]; and glutamine/
glutamate/gamma-aminobutyric acid (GABA) (‘‘Glx’’).
Recent 1H-MRS studies in ASD patients showed gener-
ally decreased NAA [124, 125], Cr?PCr, choline, and
Glx [125], as well as increased Glx in adults [126].
However, previous studies also exhibited some
inconsistencies, such as decreased [127–131], unchanged,
or increased NAA in ASD children compared with con-
trols [127, 132–135]. In the following, we categorize the
recent 1H-MRS studies in young individuals with ASD
according to the four main detectable chemical metabo-
lites: Cr?PCr, NAA, choline, and Glx. Table 4 summa-
rizes the findings of MRS studies in children.
Table 3 Resting-state functional MRI studies in ASD children.
Reference Age range (years) Seed brain regions Findings in ASD group
Di Martino et al. (2011) [114] 7–13 Striatal regions (caudate, putamen) : Connectivity in striatal-cortical circuitry
: Striatal functional connectivity with the
pons
: Connectivity of brainstem area, with
bilateral insular regions
Lynch et al. (2013) [115] 7–12 Precuneus ; Connectivity to cuneus, caudate, and
thalamic nuclei
Posterior cingulate cortex : Connectivity to medial and anterolateral
temporal cortex, lingual gyrus, posterior
parahippocampal gyrus, temporal pole,
entorhinal cortex, and perirhinal cortex
within the anterior aspect of the medial
temporal lobe
Retrosplenial cortex : Connectivity to inferior frontal and
middle frontal gyrus, dorsal medial
prefrontal cortex, posterior insular
cortex, lingual gyrus, posterior
parahippocampal gyrus, temporal pole,
posterior superior temporal sulcus, and
anterior supramarginal gyrus
Uddin et al. (2013) [116] 7–12 Anterior cingulate cortex : Connectivity to superior frontal gyrus,
thalamus, and bilateral insular cortex
Precuneus : Connectivity to posterior cingulate
cortex and left angular gyrus
Superior temporal gyrus : Connectivity to middle temporal gyrus
Postcentral gyrus : Connectivity to precentral gyrus, left
posterior insular cortex, and thalamus
Lateral occipital cortex : Connectivity to intracalcarine cortex,
and occipital pole
Wiggins et al. (2011) 119] 10–18 Right superior frontal gyrus ; Connectivity to posterior superior
frontal gyrus
Rudie et al. (2012) [118] 10–15 (?/-MET mutation)Posterior cingulate cortex ; Connectivity of overall default mode
network
; Connectivity to medial prefrontal cortex
in MET-homozygous
; Connectivity to medial prefrontal cortex
within ASD group
Abrams et al. (2013) [117] 8–12 Posterior superior temporal sulcus ; Connectivity of bilateral ventral
tegmental area, nucleus accumbens,
putamen of basal ganglia, ventromedial
prefrontal cortex, left caudate, anterior
insular cortex, and orbitofrontal cortex
Nair et al. (2013) [95] 9–17 Right thalamus
Thalamus
: Connectivity to temporal areas
; Connectivity to prefrontal, parietal-
occipital, and somatosensory cortical
regions
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Creatine and Phosphocreatine
In 1H-MRS, Cr and PCr are quantified together [136]. They
play a crucial role in the adenosine triphosphate (ATP) and
adenosine diphosphate (ADP) energy-transfer process.
ATP results from oxidative phosphorylation in neuronal
and glial mitochondria and glycolysis in the cytosol. A
phosphate bond is released from ATP through the enzyme
creatine kinase to store energy. The free phosphate bond
then binds with Cr to form PCr. When cellular
Table 4 MRS studies in ASD children.
Reference Age range
(years)
Cr?PCr NAA Cho Glx Findings in ASD group
Friedman et al. (2003) [129] 3–4 H H H ; Cr?PCr in frontal, parietal, temporal, occipital and
thalamus
; NAA in bilateral frontal, parietal, and cingulate areas,
and in right superior temporal gyrus and left putamen
; Cho in cortical areas, temporal lobes, and thalamus
DeVito et al. (2007) [128] 6–17 H H H H ; Cr?PCr in GM of frontal, temporal, occipital cortices
and cerebellum
; Cho in cortical areas, temporal lobes, and thalamus
; Glx in GM of frontal, occipital, and temporal regions
as well as cerebellum
Hardan et al. (2008) [130] 8–15 H H H ; Cr?PCr in bilateral thalamus
; Cho in cortical areas, temporal lobes, and thalamus
: Glx of thalamus is associated with abnormal sensory
sensitivity and deficits in body movement modulation
Corrigan et al. (2013) [138] 3–4 H H H H ; Cr?PCr in GM and WM generally
; Cho in cortical areas, temporal lobes, and thalamus
generally
Levitt et al. (2003) [131] 5–16 H H H ; Cr?PCr in frontal, parietal, temporal, occipital, and
thalamus
; NAA in bilateral frontal and parietal areas, and in the
left caudate
; Cho in cortical areas, temporal lobes, and thalamus
: Cho in caudate, anterior cingulate cortex and
hippocampus-amygdala complex
Friedman et al. (2006) [144] 3–4 H H H H ; NAA in both GM and WM generally
; Cho in cortical areas, temporal lobes, and thalamus
Corrigan et al. (2013) [138] 3–4 H H H H ; NAA in both GM and WM in cortical regions
; Glx in both cortical GM and WM generally
Fujii et al. (2010) [145] 2–13 H H H ; NAA/Cr?PCr in anterior cingulate cortex and a
deficit in executive functions
Fayed et al. (2005) [178] 2–10 H H ; Cho in both GM and WM of cortical areas, temporal
lobes and thalamus
Vasconcelos et al. (2008) [148] 6–10 H H H H ; Cr?PCr in cerebellum and striatum
; NAA in frontal areas
: Cho in caudate, anterior cingulate cortex, and
hippocampus-amygdala complex
Gabis et al. (2008) [146] 8–14 H H ; NAA in Hippocampus-amygdala complex
: Cho in caudate, anterior cingulate cortex, and
hippocampus-amygdala complex
Doyle-Thomas et al. (2014) [151] 7–18 H H H H ; Glx/Cr?PCr in cerebellum and : Glx/Cr?PCr in
putamen
; NAA/Cr?PCr in thalamus and : NAA/Cr?PCr in
caudate
Cho, Choline; Cr?PCr, creatine and phosphocreatine; Glx, glutamine,glutamate and GABA; GM, grey matter; NAA, N-acetylaspartate; WM,
white matter.
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mitochondria require energy, ADP and a third phosphate
bond are resynthesized to ATP via oxidative phosphory-
lation [122, 136, 137]. Cr is highly-expressed in the
mitochondria of neurons and is crucial for cellular energy
production and in the maintenance of cortical homeostasis
[122, 137].
In children with ASD, reduced Cr?PCr levels have been
reported across the cortical regions [128–130, 138]. Turner
and Gant (2014) reviewed the biochemistry of Cr and
revealed an association between reduced Cr?PCr and
ASD-like behaviors, such as abnormal learning skills,
intellectual disability, and repetitive and compulsive
behaviors. This correlation could be due to delayed or
impaired axon growth during brain development, in which
Cr?PCr are crucial elements [139]. However, no correla-
tion between Cr?PCr levels and autistic symptom severity
has been found in children with ASD [140]. Moreover,
cortical Cr?PCr is commonly considered to be stable and
has been extensively used as a reference for other
metabolites [120, 122, 127, 136].
N-Acetylaspartate (NAA)
NAA is synthesized in the mitochondria of neurons and is
catabolized in glial cells and oligodendrocytes, acting as a
precursor of fatty-acids to form the myelin around axons
[137]. Quantified by 1H-MRS, the NAA level is considered
to reflect neuronal density, integrity, and metabolism
[104, 131, 136, 141]. It is well accepted that NAA is
comparable across both GM and WM, while it is more
abundant in WM than in GM, due to its role in transmission
of action potentials [142, 143].
Research on NAA has revealed a consistent phe-
nomenon, i.e., it is generally reduced in children with ASD.
In a group of 3–4 year-old ASD children, Friedman et al.
(2003) reported NAA reduction in the frontal, parietal, and
cingulate areas of both hemispheres, as well as in the right
superior temporal gyrus and left putamen, compared with
typically-developing children [129]. In an older group of
ASD children with a mean age of 10.4 years, Levitt et al.
(2003) revealed similar findings of reduced NAA in both
left and right frontal and parietal areas, as well as in the left
caudate. They also claimed that reduced parietal axon
density, marked by reduced WM NAA, is associated with
deficits in eye gaze, spatial perception, and memory [131].
Comparing children with ASD and those with pervasive
developmental disorder, Friedman et al. (2006) found an
extensively decreased NAA level in the ASD group across
both GM and WM [144]. Similarly, Corrigan et al. (2013)
found a general NAA reduction across most cortical
regions in both GM and WM [138]. Interestingly, Fujii
et al. (2010) reported a relationship between a reduced
NAA/Cr?PCr ratio in the anterior cingulate cortex and a
deficit in executive functions. Moreover, they also found a
correlation between decreased NAA/Cr?PCr and social
and communication disabilities [145].
Choline
Choline is synthesized in the liver and is essential for the
synthesis of the neurotransmitter acetylcholine. Choline-
containing compounds along with membrane phospho-
lipids make up 40% of myelin. In 1H-MRS, the choline
level is highest in the WM [120]. The cortical choline
levels indicate the equilibrium of neuronal cellular mem-
brane phospholipid metabolism [120, 137, 146, 147].
In children with ASD, choline-containing compounds
are generally decreased in cortical areas, the temporal
lobes, and thalamus [128–131, 138], indicating a deficit in
membrane phospholipid turnover. However, studies have
also reported increased choline levels in ASD children in
different brain regions, e.g. caudate, anterior cingulate
cortex, and hippocampus-amygdala complex
[131, 146, 148]. Even though the findings are contradic-
tory, they revealed a similar phenomenon, that ASD chil-
dren have neural maturation different from typically-
developing children.
Glx (Glutamate, Glutamine, and GABA)
Glx are the most abundant neurotransmitters (90% in
synapses), taking up to 60%–80% of the glucose oxidation
and energy consumption in cortical neurons [149, 150].
They are most concentrated in GM and play essential roles
in neural migration, differentiation, and plasticity
[125, 132, 136, 140]. In ASD children, De Vito et al.
(2007) reported extensive reduction of Glx in the GM of
frontal, occipital, and temporal regions as well as the
cerebellum [128]. Corrigan et al. (2013) reported a general
decrease in Glx in both cortical GM and WM [138]. Har-
den et al. (2008) pointed out that abnormal sensory sensi-
tivity and deficits in body movement modulation are
associated with increased thalamic Glx [130]. In addition,
Doyle-Thomas et al. (2014) demonstrated that an increased
thalamic Glx level is associated with disabled social
interaction [151].
MRI and Genetics
As outlined in the introduction, ASD has a strong genetic
basis. Biological studies have revealed that many ASD-
related genes influence the formation of neuronal circuits
[21, 152, 153]. However, little is known about how these
genes affect brain structure and function. As reviewed
above, altered brain structures and functions have
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continuously been reported in ASD with a satisfying
amount of consistency. Since brain structure and function
are heritable [21, 154–156], gene-related imaging may
serve to demonstrate the possible neural mechanisms
through which phenotypic heterogeneity arises from
genetic heterogeneity in ASD [21].
One innovative gene-related imaging study has com-
pared ASD children carrying positively testable
ASD-related gene(s) with typically-developing controls
[118]. In particular, the authors were interested in the
MET (Met Receptor Tyrosine) gene. They combined
fMRI, rs-fMRI, and DTI in a large sample of ASD
children (n = 164) with MET gene classification and
controls. Indeed, the presence of risk alleles in ASD
children had a significantly larger impact on functional
connectivity than controls. In the ASD risk-allele group,
the fMRI showed reduced functional connectivity from
posterior cingulate to medial prefrontal cortex. DTI
exhibited decreased FA in the splenium portion of the
CC that connects to the posterior cingulate. Moreover,
group-by-genotype interactions revealed more deactiva-
tion of the posterior cingulate, medial prefrontal, and
primary auditory cortices, lower functional connectivity
of these regions, and lower WM integrity in tracts con-
necting these regions (splenium, cingulum, and superior
and inferior longitudinal fasciculus). Investigating the
impact of another ASD-related gene (CNTNAP2; con-
tactin-associated protein-like 2), Scott-Van Zeeland et al.
(2010) revealed that risk-allele-carrying ASD children
showed a pattern of diffusely increased functional con-
nectivity between the frontal cortex and temporal lobes,
while typically-developing controls exhibited a clear
connectivity between frontal cortex- and language-related
cortical regions [157].
According to these limited findings, we can only spec-
ulate that ASD-related genes may contribute to atypical
connectivity and development. More studies combining
genetic information and multimodal neuroimaging data are
needed to understand the relationship between heteroge-
neous neuropathological phenotypes and the clinical man-
ifestations of ASD, as well as to improve diagnostic tools
and treatment strategies [158].
Support Vector Machine Technologies
The findings of MRI studies have substantially advanced
our understanding of the neural mechanisms underpin-
ning ASDs. However, the integration of neuroimaging
tools into clinical practice has so far been limited, partly
because it is unclear which information revealed by these
tools is relevant to diagnosis and treatment decisions.
Support Vector Machine (SVM) technology is a specific
type of supervised machine learning that aims to classify
data points by maximizing the margin between classes in
a high-dimensional space [159, 160]. The optimal SVM
algorithm is developed through a ‘‘training’’ phase in
which training data are used to develop an algorithm
able to discriminate between groups previously defined
by the operator (e.g. patients versus controls). Once a so-
called ‘‘decision function’’ or ‘‘hyperplane’’ is learned
from the training data, it can be used to predict the class
of a new test example. The interesting aspect of the
SVM is that it is multivariate and takes into account
inter-regional correlations. Therefore, it is extremely
well-suited to take into account and test subtle differ-
ences in intra-regional correlations of brain metabolism,
function, and anatomy [161, 162]. This may be of par-
ticular relevance to ASD, in which the abnormalities are
usually in the development of the whole neural system
rather than isolated regions.
SVMs have been widely used to aid the diagnosis of
neurological disorders, such as Alzheimer’s disease
[163–166] and Parkinson’s disease [167, 168], as well as
to identify those brain areas in stroke patients that are
involved in a particular (cognitive) function [169, 170].
Among ASD patients, the SVM was first applied in
adults. Singh et al. developed a diagnostic model gen-
erated by the LPboost-based algorithm to distinguish
autistic children from controls, based on voxel-wise
cortical thickness and *40,000 points for each individ-
ual; they reported 89% classification accuracy based on
cross-validation [171]. Ecker et al. (2010) applied SVM
classifiers to investigate the predictive value of whole-
brain structural volumetric changes in ASD, and obtained
81% classification accuracy based on cross-validation
[172]. More recently, Ecker et al. (2013) pooled regional
WM and GM volumes in ASD patients using SVMs and
classified ASD patients with a high true positive rate
[173]. As for ASD children, the number of reports is
relatively limited. In a group of ASD children (mean age
9.2 ± 2.1 years), Jiao et al. (2010) used 4 different
machine-learning techniques (including SVMs) to gen-
erate diagnostic models from both the VBM and SBM
results. They reported a better classification performance
for the thickness-based data than those based on regional
volumes [44]. Lately, Jin et al. (2015) used an SVM
classifier to identify high-risk ASD infants from WM
tracts and whole-brain connectivity. Their proposed
function achieved an accuracy of 76% and an area of 0.8
under the receiver operating characteristic curve [174].
To conclude, SVM technology is extremely promising
in its contribution to an accurate and valid diagnosis of
ASD. However, for ASD in children, the application of
SVM is still at the beginning. More studies are needed to
produce reliable diagnostic models based on imaging data.
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Summary and Future Direction
The main findings of MRI studies in children are summa-
rized in Table 5.
Young ASD children exhibit differences in brain mor-
phometry, neurochemical components, and structural and
functional connectivity. So far, a diverse set of potential
biomarkers including genetic, biochemical, morphological,
hormonal, immunological, neuropathological, neuropsy-
chological, and behavioral biomarkers have been identi-
fied. However, for most of these markers it is not yet clear
if they are contributing factors to the development of ASD
or are a result of another underlying abnormality. Longi-
tudinal studies - especially covering very young children
with ASD - may help answer this question.
It shouldbekept inmind thatMRI techniques are limited to a
certain level of spatial and temporal resolution. If this level is
not precise enough to visualize the synaptic or neuronal
abnormalities where the core features or heterogeneity of ASD
arises neuroimaging may ultimately not be the best tool for
parsing these differences. However, in combination with post-
mortem tissue analysis or animalmodels, neuroimaging studies
Table 5 Summary of main MRI findings.
MRI approaches Findings
Structural MRI Cortex
Increased total GM and WM volumes
Increased GM and WM volumes in frontal and temporal areas
Increased cingulate cortex
Atypical variation of cortical thickness in frontal, temporal, and parietal lobes






Increased volumes in younger children bilaterally






Atypical shapes of the structures
Hippocampus
Increased size of hippocampi in young children
Enlargement located especially on the right side
No difference between sides in older children
Diffusion tensor imaging Decreased FA in the whole brain, frontal lobe, arcuate fasciculus, across the entire CC, and in anterior thalamic
radiation
Increased FA in arcuate fasciculus and in CC in young children
Increased MD in whole brain, frontal and temporal lobes, and across the entire CC
Resting-state fMRI Altered functional connectivity in the default mode network
Hyper-connectivity in striatal-cortical circuitry, precuneus, cingulate cortex, and temporal-frontal circuity
Under-connectivity in anterior-posterior connections
Magnetic resonance
spectroscopy
Decreased NAA levels in general GM and WM, especially in frontal, temporal, cingulate, and caudate areas
Decreased Cr?PCr levels in general GM and WM, especially in frontal, parietal, temporal, occipital cortex, and
thalamus
Decreased choline levels in cortical areas, temporal lobes, and thalamus
Increased choline levels in caudate, anterior cingulate cortex, and hippocampus-amygdala complex
Decreased Glx in GM of frontal, occipital, temporal cortex, and cerebellar regions
Increased Glx in thalamus and putamen
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have the potential to provide a critical intermediate step
between the genetic basis and the phenotype. Such approaches
allowus to deconstruct the conceptions ofASDdeeply towhere
they can be grounded in biology [87, 175].
While most of the studies reviewed here are still char-
acterized by methodological variability and relatively small
sample sizes, studies with pooled data samples and
homogeneous analytical approaches are needed. Large-
scale collaboration networks of that type are ABIDE
(‘‘Autism Brain Imaging Data Exchange’’) [114, 176, 177]
and NDAR (‘‘National Database for Autism Research’’).
They combine imaging data from multiple sites and inte-
grate both genetic and behavioral data. These projects will
allow researchers to achieve sufficient power to detect true
brain-gene-behavior relationships [21]. In general, multi-
site and multi-modal studies based on large patient groups
is one of the key strategies to increase the probability of the
discovery of new effective biomarkers in ASD and to
comprehensively characterize the clinical, behavioral, and
cognitive symptoms of this disorder.
Along with the growing numbers of gene-related MRI
studies, the application of multimodal MRI scanning and
collaboration networks, as well as advanced analytical
methods are needed. Techniques, such as a machine
learning classifier or prediction, may serve to identify
patterns of biomarkers across different modalities, relevant
to clinical diagnosis and genotype, severity rating, prog-
nosis, and/or response to treatment. Last but not least,
further large-sample studies on ASD children are needed to
search for reliable biomarker patterns and diagnostic
models based on imaging data.
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